biotech · HER2 Positive Breast Cancer
Prestige BioPharma
Prestige Biopharma Belgium
Prestige Biopharma Belgium is a biotech organization headquartered in EU. Primary therapeutic focus areas include HER2 Positive Breast Cancer. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent r
Seoul, KR HQ
1 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Seoul, KR
- Employees
- 1
- Programs
- 2
- Drugs
- 0
- Patents
- 0
HD201
Phase 3 · small molecule · HER2 Positive Breast Cancer
HD201 for HER2 Positive Breast Cancer is a Phase 3 program (small_molecule) at Prestige Biopharma Belgium with 1 ClinicalTrials.gov record(s).
Internal code TROIKA
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Prestige Biopharma Belgium
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- HER2 Positive Breast Cancer
- Status
- completed
- Trials
- 1